Ivonescimab 10 mg/kg
GORTEC 2024-04
Phase 3 small_molecule active
Quick answer
Ivonescimab 10 mg/kg for Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) is a Phase 3 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active